Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular

Tae Ho Lee1, Chun-Hau Chen, Futoshi Suizu

  • 1Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

Molecular Cell
|April 19, 2011
PubMed

Insights

Death-associated protein kinase 1 (DAPK1) inactivates the enzyme Pin1 by phosphorylating it. This DAPK1-mediated Pin1 phosphorylation inhibits cancer-promoting activities like centrosome amplification and cell transformation.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cancer Biology

Background:

  • Pin1 is a critical regulator of signaling pathways implicated in diseases, particularly cancer.
  • The regulation of Pin1's catalytic activity, often presumed to be constitutive, remains poorly understood.

Purpose of the Study:

  • To investigate the regulatory mechanisms controlling Pin1's catalytic activity and cellular functions.
  • To identify kinases that phosphorylate and modulate Pin1 activity.

Main Methods:

  • Kinase assays to identify DAPK1 as a Pin1 kinase.
  • Site-directed mutagenesis to confirm Ser71 phosphorylation.
  • Cellular localization studies and functional assays (centrosome amplification, cell transformation).
  • Correlation analysis in human breast cancer tissues.

Main Results:

  • Death-associated protein kinase 1 (DAPK1) phosphorylates Pin1 at Ser71 within its catalytic active site.
  • Phosphorylation at Ser71 completely inactivates Pin1's catalytic activity and prevents its nuclear translocation.
  • DAPK1-mediated Pin1 inhibition reduces centrosome amplification and cell transformation.
  • Elevated Pin1 pSer71 levels correlate with higher DAPK1 levels and reduced centrosome amplification in breast cancer.

Conclusions:

  • DAPK1 acts as a negative regulator of Pin1 by phosphorylating Ser71, thereby inhibiting its enzymatic activity and oncogenic functions.
  • Pin1's catalytic activity is essential for its cellular roles, and its regulation by phosphorylation is a key mechanism.
  • This finding highlights a novel regulatory axis with potential implications for cancer therapy.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...